P
Pulike Biological Engineering Inc
SSE:603566
Pulike Biological Engineering Inc
SSE:603566
Price:
13.81
CNY
0.66%
Market Closed
Market Cap:
¥4.8B
Relative Value
The Relative Value of one Pulike Biological Engineering Inc stock under the Base Case scenario is 13.81 CNY. Compared to the current market price of 13.81 CNY, Pulike Biological Engineering Inc is Fairly Valued.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
13.81
CNY
Fairly Valued
P
Multiples Across Competitors
Competitors Multiples
Pulike Biological Engineering Inc Competitors
Pulike Biological Engineering Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
P
|
Pulike Biological Engineering Inc
SSE:603566
|
4.8B CNY | 4.3 | 33.3 | 26.6 | 26.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987.6B USD | 16.4 | 53 | 35.6 | 38.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
565.6B USD | 6 | 21 | 14.6 | 17.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
280.6B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.9B GBP | 5.1 | 31.7 | 15.1 | 22.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
223.4B CHF | 5.2 | 20.2 | 12.7 | 16.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.6B USD | 4.5 | 15.1 | 10.7 | 12.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK | 5.2 | 15.9 | 11 | 12.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD | 2.4 | 15 | 7.6 | 10.4 | |
| FR |
|
Sanofi SA
PAR:SAN
|
97.3B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
